Clinical Study Evaluating The Role of Vonoprazan Versus Pantoprazole in Patients With Gastroesophageal Reflux Disease

NCT06564246 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Gastroesophageal Reflux Disease (GERD)

Interventions

DRUG: Vonoprazan 20 mg versus Pantoprazole 40 mg

Sponsor

Tanta University